AKT1 and hepatocellular carcinoma: In hepatocellular carcinoma and glioblastoma, upregulation of IGF2BP3 increased c-Myc expression and activated PI3K-AKT pathway, thereby affecting cell proliferation, cell cycle, and apoptosis (40, 41).